Geranylgeranyltransferase I as a target for anti-cancer drugs
Open Access
- 1 May 2007
- journal article
- review article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 117 (5), 1223-1225
- https://doi.org/10.1172/JCI32108
Abstract
Posttranslational modification is critical for the function of the gene products of ras oncogenes, which are frequently mutated in cancer. Ras proteins are modified by farnesyltransferase (FTase), but many related small GTPases that also end in a CAAX motif (where C is cysteine, A is often an aliphatic amino acid, and X is any amino acid) are modified by a closely related enzyme known as geranylgeranyltransferase type I (GGTase-I). Accordingly, inhibitors for both of these enzymes have been developed, and those active against FTase are in clinical trials. In this issue of the JCI, Sjogren et al. report the development of a mouse strain homozygous for a conditional allele of the gene that encodes GGTase-I (see the related article beginning on page 1294). They found that ablation of the GGTase-I–encoding gene in cells destined to produce lung tumors driven by oncogenic K-Ras resulted in delayed onset and decreased severity of disease, validating in a genetic model the theory that GGTase-I is a good target for anti-cancer drug development.Keywords
This publication has 20 references indexed in Scilit:
- GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS–induced lung cancerJCI Insight, 2007
- Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitorsJournal of Lipid Research, 2006
- Crystallographic Analysis of CaaX Prenyltransferases Complexed with Substrates Defines Rules of Protein Substrate SelectivityJournal of Molecular Biology, 2004
- RAL GTPases are linchpin modulators of human tumour‐cell proliferation and survivalEMBO Reports, 2003
- Distinct requirements for Ras oncogenesis in human versus mouse cellsGenes & Development, 2002
- An essential role for Rac in Ras transformationNature, 1995
- Protein farnesyltransferase and geranylgeranyltransferase share a common α subunitCell, 1991
- Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptidesCell, 1990
- Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation.Proceedings of the National Academy of Sciences of the United States of America, 1990
- p21ras is modified by a farnesyl isoprenoid.Proceedings of the National Academy of Sciences of the United States of America, 1989